F. V. DeFeudis
Centre national de la recherche scientifique
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by F. V. DeFeudis.
Journal of Neurochemistry | 1980
F. V. DeFeudis; L. Ossola; Gaby Schmitt; Pierre Wolff; P. Mandel
y-AMINOBUTYRIC acid (GABA) is bound to particulate preparations of the vertebrate CNS by highaffinity processes in the absence of added Na+, and it is believed that such processes represent interactions of GABA and its synaptic receptors (e.g. Enna and Snyder, 1975: reviews by DeFeudis, 1977 and Johnston, 1978). In order to examine this hypothesis further, the binding of [RH]GABA and of the potent GABA-agonist, [3H]muscimol, to subcellular particles of whole brain and of neurone-enriched and astroblast cultures have been compared.
Neuroscience Letters | 1979
F. V. DeFeudis; L. Ossola; Gaby Schmitt; P. Mandel
High-affinity, Na+-independent binding of [3H]muscimol (KB approximately equal to 1.6 x 10(-8) M; Bmax approximately equal to 0.14 nmol/g pellet) occurred to a frozen-thawed particulate fraction of 74-h-old neurone-enriched cultures prepared from the cerebra of 12-13-day-old rat embryos. This finding provides evidence that GABA-receptors exist on cultured neurones which contain only a few synaptic connections.
Biochemical Pharmacology | 1979
F. V. DeFeudis; L. Ossola; P. Mandel
Abstract Muscimol (3-hydroxy-5-aminomethylisoxazole), a conformationally-restricted analogue of γ-aminobutyric acid (GABA), exerts pronounced bicuculline-sensitive depressant actions when applied iontophoretically to neurones of the mammalian CNS (1,2). Recent in vitro studies have revealed further that muscimol is about 5 – 10 times more potent than GABA itself at competing with [ 3 H]GABA or [ 3 H]bicuculline-methiodide for membrane binding sites of rat brain (3–5) and that [ 3 H]muscimol is bound to various CNS particulate fractions by mechanisms that involve one or two populations of high-affinity sites (6–9). However, except for one preliminary report (10), no studies have been aimed at comparing the maximal binding capacities (B max ) of muscimol and GABA in a CNS preparation. Herein, we present such data.
Journal of Neurochemistry | 1980
F. V. DeFeudis; L. Ossola; Gaby Schmitt; P. Mandel
Abstract: The effects of some GABA analogues and some drugs on the binding of [3H]muscimol (3.08 nM) to thoroughly washed subcellular particles prepared from a neuron‐enriched culture of embryonic rat brain were examined using Na+‐free Tris‐citrate medium and a centrifugation method. Competition for [3H]muscimol binding sites by excess(10−5 M) unlabelled GABA provided estimates of “specific” binding. In accord with in vivo neuropharmacological studies on GABA receptors and with in vitro studies on cerebral membrane preparations, [3H]muscimol binding was potently inhibited by muscimol itself (IC50, 2.5 nM), GABA (1C50, 43 nM), isoguvacine (IC50, 61 nM), and 3‐aminopropanesulphonic acid (IC50, 160 nM), and less potently inhibited by the GABA antagonist bicuculline methobromide (IC50, 800 nM). δ‐ Aminovaleric acid (IC50, 2.6 μM), the glycinelp‐alanine antagonist strychnine (IC50, 6.6 μM), and the predominantly glial GABA uptake inhibitors β‐alanine (IC50, 23 μM) and p‐proline (IC50, 66 μM) also inhibited [3H]muscimol binding. Other inhibitors of Na+‐dependent GABA uptake, (±)‐nipecotic acid, L‐ 2,4‐diaminobutyric acid, and guvacine, as well as picrotoxinin, were relatively inactive as inhibitors of [3H]muscimol binding (IC50≥ 1 mM). In addition to revealing that GABA receptors are present on neuronal membranes before the formation of most synapses, this binding of [3H]muscimol that occurs to neuronal, but not to glial, membranes might be useful as a “neuronal marker” and for the further characterization and isolation of GABA receptors.
Neuroscience | 1979
F. V. DeFeudis; Michel Maitre; Lucienne Ossola; Alice Elkouby; Guy Roussel; P. Mandel
Abstract The binding of low concentrations of [ 3 H]y-aminobutyrate (GABA) to a synaptosomal fraction of rat cerebral, cortex was studied in the presence and absence of added Na + ; unlabelled GABA and bicuculline methiodide were used to estimate ‘GABA-sensitive’ and ‘bicuculline-sensitive’ binding sites. Significant amounts of [ 3 H]GABA were bound to the particles in both the presence and absence of added Na + . In Na + -free medium, a single bicuculline-sensitive, high-affinity [ 3 H]GABA binding process was detected, its GABA-sensitive sites having K B ∼- 10 −5 M . In Na + -containing medium, two bicuculline-sensitive, high-affinity [ 3 H]GABA binding processes were detected, the lower-affinity process having GABA-sensitive sites with K B ∼- 10 −5 M and the higher-affinity process having GABA-sensitive sites with K B ∼- 4 × 10 −8 M Our findings suggest that bicuculline-sensitive components of [ 3 H]GABA binding in the absence of Na + and in the presence of Na + (higher-affinity process) could represent estimates of Na + -indepen dent and Na + -dependent synaptic GABA-receptors. The bicuculline-sensitive component of lower-affinity [ 3 H]GABA binding in the presence of Na + might be related to an action of bicuculline on GABA transport. Two GABA-receptor agonists displaced about the same amount of [ + H]GABA as did bicuculline in Na + -free medium, indicating further that a synaptic GABA-receptor was involved in [ 3 H]GABA binding under these conditions. Nipecotic acid markedly inhibited [ 3 H]GABA binding in both the presence and absence of added Na + , indicating that some transport sites become occupied by GABA in the absence of added Na + and that nipecotic acid might interact to some extent with synaptic GABA-receptors.
General Pharmacology-the Vascular System | 1979
F. V. DeFeudis; L. Ossola; P. Mandel
Abstract 1. Over an identical concentration range (3.08 × 10−9−3.08 × 10−8 M), both [3H]GABA and [3H]muscimol were bound to a particulate fraction of rat brain by high-affinity processes in the absence of added Na+. 2. Components of these processes that were displaceable by excess unlabelled GABA had K B ⋍ 2 × 10 −7 M and B max ⋍ 1 pmol/mg protein for [3H]GABA and K B ⋍ 7 × 10 −8 M and B max ⋍ 1.9 pmol/mg protein for [3H]muscimol. 3. Pellet/supernatant distribution ratios and Bmax values indicated that more [3H]muscimol sites than [3H]GABA sites exist in rat brain. 4. [3H]Muscimol binding sites need not be the same as those that bind [3H]GABA to be sensitive to excess unlabelled GABA. 5. The concept of “specific” GABA binding is further qualified.
General Pharmacology-the Vascular System | 1983
E. Mesdjian; F. V. DeFeudis; M. Valli; G. Jadot; P. Mandel
The antinociceptive action of sodium valproate (VPA) was examined using male NMRI mice. Using the hot-plate assay at 60 degrees C, orally-administered VPA (50-400 mg/kg) produced antinociceptive effects; the ED50 was about 160 mg/kg. Oral doses of VPA (6.3-400 mg/kg) decreased the writhing response elicited by intraperitoneally-injected acetic acid. The antinociceptive effect of VPA, as determined with the writhing test, exhibited complex characteristics, the most pronounced effect occurring at doses of 12.5-50 mg/kg. The antinociceptive effect of VPA in the writhing test was not antagonized by bicuculline or by naloxone. VPA, like other agents which enhance central GABA-ergic mechanisms, might possess analgesic activity.
General Pharmacology-the Vascular System | 1980
F. V. DeFeudis; A.N.K. Yusufi; L. Ossola; Michel Maitre; Pierre Wolff; G. Rebel; P. Mandel
Abstract 1. 1. The effects of various rabbit sera on the binding of [ 3 H]GABA (4.6 × 10 −9 M) and on the retention of [ 14 C]sucrose (1.04 × 10 −7 M) in a synaptosome-enriched fraction of rat cerebral cortex were examined using differential centrifugation and double-isotope methods. 2. 2. Additions of undiluted whole sera (amounting to about 1 5 th of the total volume of suspensions) decreased the binding of [ 3 H]GABA, did not affect the retention of [ 14 C]sucrose and increased pellet/supernatant [ 14 C]sucrose distribution ratios and protein contents of pellets. 3. 3. Only antiserum to total gangliosides-plus-albumin significantly decreased the binding of [ 3 H]GABA to a greater extent than did control serum; this effect was not due to albumin antibodies since antiserum to albumin did not affect [ 3 H]GABA binding and it was not due to increased protein content of pellets since serum containing hemolyzed erythrocytes (which had a higher protein content than other sera) did not affect [ 3 H]GABA binding. 4. 4. Gangliosides might be involved in modulating the interaction of GABA and its synaptic receptors and/or its transport sites.
Cellular and Molecular Life Sciences | 1980
Louis L. Sarliève; F. V. DeFeudis; L. Ossola; P. Mandel
Binding of [3H]GABA and [3H]muscimol, indicative of GABA-receptors, has been demonstrated in a neurone-enriched culture of embryonic mouse brain using a ligand-binding technique. Evidence is provided for the existence of different populations of GABA-receptors.
Biochemical Pharmacology | 1980
V. Varga; F. V. DeFeudis; L. Ossola; Michel Geffard; P. Mandel
Abstract The binding of [ 3 H]γ-aminobutyric acid ([ 3 H]GABA) and [ 3 H]muscimol to subcellular particles of brain, which occurs in the absence of added Na + (i.e., “Na + -independent binding”), has been used to estimate synaptic GABA-receptors (1–3). This binding appears to be most enriched in crude synaptic membrane fractions of brain (4–6), but all of the binding sites do not appear to be localized to synaptic membranes (e.g., 2,7,8). Recent studies have revealed further that the highest-affinity process for [ 3 H]muscimol binding to subcellular particles of rat brain has a higher capacity than that of [ 3 H]GABA (9–12). Herein, the binding of these ligands to sub-fractions of a crude membrane fraction of rat brain are compared.